4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-26-000120
EVP, Chief Reg. & Quality Off. sold 260 shares at $486.35 ($126,451)
- EVP, Chief Reg. & Quality Off. gave up 1,627 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Tatsis Ourania · EVP, Chief Reg. & Quality Off.
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-24 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −1,627 | $485.11 | $789,274 | 47,023 | D |
| 2026-02-25 | Sale : show line 2 in the form 10b5-1 | −260 | $486.35 | $126,451 | 46,763 | D |
| Open-market sales · 260 sh · avg $486.35 · $126,451 | ||||||
Loading xslF345X05/wk-form4_1772150109.xml…